ALLG | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,456 results for “ALLG”

Trials

View all 2054 →

Active, not recruiting

ALLG AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): A Multi-arm, Precision-based, Recursive, Platform Trial

3 participants · First posted Oct 30, 2024

Not yet recruiting

A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular Lymphoma

138 participants · First posted Jul 30, 2026

Type 2 Diabetes Mellitus: New Approaches to Optimize Medical Care in General Practice

204 participants · First posted Aug 27, 2008

Drugs

View all 98 →

Protein therapeutics(Allgenesis Biotherapeutics)

ALLO-316

Organizations

View all 35 →

Allgemeine Unfallversicherungsanstalt

Austria

SEGEBERGER KLINIKEN GMBH

Germany

ALLGENESIS BIOTHERAPEUTICS INC.

Taiwan

News

View all 269 →

Cyclophosphamide Plus Cyclosporin Emerges as New Standard of Care for GVHD Prevention in Blood Cancer Transplants

Mendus Reports Promising Long-Term Survival Data for Vididencel in Acute Myeloid Leukemia

EHA 2025 Showcases Breakthrough Therapies for Hematologic Malignancies

Page 1 of 246